EUVIMEDEUVIMED entdecken
Open Access

Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be

Colleen Jay, Jesse D Schold

Current Transplantation Reports · 2017-03 · 4 (1) · 52-58

DOI: 10.1007/s40472-017-0138-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Transplantation Reports, online erschienen am 08.02.2017. Verfasst von Colleen Jay und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Transplant Center, University of Texas Health Science Center, San Antonio. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: Risks of regulatory scrutiny has generated widespread concern about increasingly risk averse transplant center behaviors regarding both donor and candidate acceptance patterns. To address potential unintended consequences threatening access to care, we discuss recent changes in regulatory metrics and potential improvements in quality oversight of transplant centers. RECENT FINDINGS: Despite many recent changes to one-year patient and graft survival regulatory criteria, the capacity to accurately identify true underperforming centers and avoiding false positive flagging remains an area of great concern. Numerous studies have demonstrated restrictions in transplant volume and access following transplant center flagging. SUMMARY: Current regulatory criteria are limited in their capacity to accurately identify poorly performing centers and potentially encourage risk-averse behavior by transplant centers. Efforts to address these concerns should focus on (1) improving risk-adjustment models with better data which captures the acuity of candidate and donor risk, (2) reconsidering primary outcomes measured to assess comprehensive transplant center performance, (3) improving education to address rational or perceived disincentives, and (4) using data more effectively to share best practices.

Schlagwörter

Stichwörter der Autor:innen

Centers for Medicare and Medicaid ServicesMembership and Professional Standards CommitteeOrgan Procurement and Transplant NetworkOrgan TransplantationPerformance metricsQualityRegulatory oversight

Autor:innen und Institutionen

  • University Transplant Center, University of Texas Health Science Center, San Antonio.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Jay, C., & Schold, J. D. (2017). Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be. Current Transplantation Reports, 4(1), 52-58. https://doi.org/10.1007/s40472-017-0138-9

Vancouver

Jay C, Schold JD. Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be. Current Transplantation Reports. 2017;4(1):52-58. doi:10.1007/s40472-017-0138-9

BibTeX
@article{Jay2017,
  author = {Jay, Colleen and Schold, Jesse D},
  title = {Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be},
  journal = {Current Transplantation Reports},
  year = {2017},
  volume = {4},
  number = {1},
  pages = {52--58},
  doi = {10.1007/s40472-017-0138-9}
}
Kostenlos starten →